Skip to content
MedCompare

Entrectinib

Also known as Rozlytrek (us)

Cancer & Oncology
Save $4,676/mo
3× cheaper

Entrectinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body.

United States
$6,592
per month
India
$1,915
per month
You save
$4,676
71% cheaper in India
1.1K US scripts/yr$5.3M potential annual savings$7.5M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC31H34F2N6O2

SMILES: CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6

Compare the price
US price$6,592per month
India price$1,915per month
You save$4,67671% less

Based on 30 units per month. US $219.73 vs India $63.84 per unit.

Total over 1 periodSave $4,676$6,592 → $1,915
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$28,059
Estimated travel cost
− $2,300
Net savings after travel
$25,759

Even after travel, you could come out ahead by about $25,759.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Entrectinib is filled about 1.1K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$7.5M
If sourced from India
$2.2M
Potential annual savings
$5.3M
−71%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.